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INTRODUCTION
Strongyloides stercoralis is an intestinal nematode of humans
with worldwide distribution which may also infects dogs, cats,
and monkeys. This parasite is most common in tropical and
subtropical regions [1,2]. The transmission can happen by autoin-
fection, which occurs when larvae in the intestine develop pre-
cociously to the infective 3rd stage larvae (L3) and invade the
intestinal wall. In this case the disease may remain chronic for
several years [3].
Strongyloidiasis presents 3 possible outcomes in the infected
hosts: (a) self-cure by S. stercoralis elimination; (b) the chronic
form supported by autoinfection; and (c) hyperinfection or the
form disseminated by larvae in ectopic sites. These factors are
highly dependent on the host immune responses and the eva-
sive capacity of the parasite [4,5]. In human strongyloidiasis,
the chronic infection, when limited to the gastrointestinal tract,
is clinically non-apparent in most cases. Hyperinfection and
dissemination can lead to the death of individuals with protein-
caloric malnutrition, cancer, renal transplant, systemic lupus
erythematosus, acquired immunodeficiency syndrome (AIDS),
or tuberculosis as well as alcoholics or those receiving treatment
with immunosuppressor drugs [3,6,7]. Here, a case of fatal
strongyloidiasis in a patient with chronic lymphocytic leukemia
(CLL) is described and a molecular diagnosis of isolate is pre-
sented.
CASE RECORD
In August 2006, a 74-yr-old male with a history of CLL and
originally a resident of Khouzestan Province (southwestern
Iran), was admitted to Al-Zahra Medical Centre in Isfahan, Iran.
The patient suffered from intestinal and respiratory disorders
including abdominal pain, cough, sputum discharge, and chest
pain, as well as weakness, dizziness, and anemia for several years.
He was taking prednisolone and ciprofloxacin during previous
2 months. Laboratory examinations at the time of hospitaliza-
tion showed hemoglobin 8.1 g/dL, the leucocyte count 37,800/
mm3, the platelet count 54,000/mm3, and an erythrocyte sedi-
mentation rate of 80 mm/hr. There were no blasts or eosino-
phils in the peripheral smear. Liver function tests showed serum
bilirubin 0.7 mg/dL, and alanine and aspartate aminotransferas-
es 20 and 65 U/L, respectively. Alkaline phosphatase was 188
U/L, and albumin 3.1 g/dL. Serum phosphorus, calcium, crea-
tinine, potassium, and sodium were 3.3 mg/dL, 8 mg/dL, 0.8
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mg/dL, 3.2 mEq/L, and 122 mEq/L, respectively. In a direct
smear and formalin-ether examinations of the diarrheic stool
sample, numerous rhabditiform larvae of S. stercoralis were pre-
sent, while in sputum smear and agar plate culture of the stool
both rhabditiform and filariform larvae (Fig. 1) were observed.
The detection of numerous larvae in both the stool and spu-
tum confirmed Strongyloides hyperinfection in this patient. No
other parasite or pathogenic bacteria were found by either stool
examination or culture. Albendazole therapy (400 mg twice
daily for 3 days) did not have cure effects; and just at the begin-
ning of putting on ivermectin, the patient died.
S. stercoralis filariform larvae recovered from agar plate culture
were preserved in 75% ethanol solution and kept at ambient
temperature for subsequent molecular processing. Total genom-
ic DNA was extracted from filariform larvae using the QIAamp
DNA Mini Kit (Qiagen, Hilden, Germany) spin column method
following the manufacturer’s instructions. For molecular typ-
ing of S. stercoralis a nested-PCR and partial sequencing of the
ITS1 region of the rDNA gene (approximately 680 bp) was per-
formed using the primer set mentioned by Nilforoushan et al.
[8]. The sequences of these 2 primer set was as follows: SS-Fo-
rward: 5′-GTA ACAAGG TTT TCG TAG GTG A-3′, SS-Reverse:
5′-ATT TAG TTT CTT TTC CTC CGC TT-3′.
Negative control (water instead of DNA template) was includ-
ed in each amplification run. The PCR product was analyzed
by electrophoresis in a 1.5% agarose gel and visualized after
ethidium bromide staining (Fig. 2). The secondary PCR prod-
uct was sequenced by SEQLAB company (Germany) with an
ABI 3100 genetic analyzer. Blasting the sequence showed that
the amplicon was definitely S. stercoralis. The sequence deter-
mined in this study has been registered in the GenBank data-
base under accession number EF653264.
DISCUSSION
Strongyloides is unique among the parasitic infections because
of its ability to autoinfect the host without soil or intermediate
host. The detection of increased number of larvae in the stool
and/or sputum is a hallmark of hyperinfection. It is often com-
plicated by infections caused by gut flora that gain access to
intestinal sites, presumably through ulcers induced by the filar-
iform larvae [6]. Strongyloidiasis can occur without any symp-
toms, or as a potentially fatal hyperinfection or disseminated
infection. Th2 cell-mediated immunity, humoral immunity
and mucosal immunity have been shown to have protective
effects against this parasitic infection especially in animal mod-
els. Any factors that suppress these mechanisms (such as inter-
current immune suppression or glucocorticoid therapy) could
potentially trigger hyperinfection or disseminated infection
which could be fatal [9].
Immunosuppressed patients are at the greatest risk because
impaired cellular and humoral immunity alter parasite prolifer-
ation, resulting in increased parasitic burden and possible dis-
semination to other organs. In this accelerated phase of autoin-
fection, enormous numbers of larvae are released into the venous
circulation and disseminate throughout the body. This poten-
tially fatal phenomenon has been described not only in patients
with AIDS but also in patients being treated with corticosteroids
and/or other immunosuppressive drugs [10]. Unfortunately,
fecal larval output does not correlate with the adult worm bur-
den and may underestimate the severity of the infection. 
In the case presented here, the patient was a resident of Kho-
uzestan Province, an endemic area for S. stercoralis with warm
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Fig. 1. A filariform larva of Strongyloides stercoralis. (A) Whole view
of the larva, (B) Nutched tail of the larva. Scale bar = 100 μm. Fig. 2. Molecular diagnosis of Strongyloides stercoralis by a nest-
ed PCR based on rDNA gene. Lane 3, molecular weight marker







climate. He suffered from intestinal and respiratory disorders
for several years; however, his infectivity with S. stercoralis was
undiagnosed till his hospitalization. In fact, altered immunity
due to the chronic CLL in this patient is most probably the pri-
mary reason for acceleration of S. stercoralis proliferation lead-
ing to hyperinfection syndrome involving both pulmonary and
gastrointestinal systems. Although, in both the stool and spu-
tum direct smears of the patient, enormous S. stercoralis larvae
were present, and no eosinophilia was found in the peripheral
blood. Therefore, in some cases of hyperinfection syndrome
and disseminated strongyloidiosis, eosinophilia could not be
found in spite that eosinophilia is the most important labora-
tory finding in patients infected with S. stercoralis [9,11].
In summary, individuals with immunodeficiency states, par-
ticularly with cell-mediated immunity defect, hematological
malignancy, steroid usage, malnutrition, diabetes, and organ
transplantation, are predisposed to this infection. Early diagno-
sis and timely therapy in case of hyperinfection syndrome can
have a marked impact on the disease outcome. In fact, recogni-
tion of risk factors for infection, including immune compro-
mise, habitation in endemic areas, and prisoner-of-war status,
may enhance detection by prompting stool studies or endoscopy.
Because clinical symptoms and endoscopic findings are non-
specific, a high level of suspicion is required for diagnosis [6].
Regular stool screening of high risk patients is necessary to mini-
mize the risk of hyperinfection and prevention of fatal conse-
quences as the case presented here. 
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